These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 32831113)

  • 1. High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center.
    Bostel T; Mattke M; Nicolay NH; Welzel T; Wollschläger D; Akbaba S; Mayer A; Sprave T; Debus J; Uhl M
    Radiat Oncol; 2020 Aug; 15(1):206. PubMed ID: 32831113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma.
    Uhl M; Welzel T; Jensen A; Ellerbrock M; Haberer T; Jäkel O; Herfarth K; Debus J
    Strahlenther Onkol; 2015 Jul; 191(7):597-603. PubMed ID: 25737378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sacral insufficiency fractures after high-dose carbon-ion based radiotherapy of sacral chordomas.
    Bostel T; Nicolay NH; Welzel T; Bruckner T; Mattke M; Akbaba S; Sprave T; Debus J; Uhl M
    Radiat Oncol; 2018 Aug; 13(1):154. PubMed ID: 30139357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol.
    Uhl M; Edler L; Jensen AD; Habl G; Oelmann J; Röder F; Jäckel O; Debus J; Herfarth K
    Radiat Oncol; 2014 Apr; 9():100. PubMed ID: 24774721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC): An open label, randomized, stratified, phase II trial.
    Seidensaal K; Froehlke A; Lentz-Hommertgen A; Lehner B; Geisbuesch A; Meis J; Liermann J; Kudak A; Stein K; Uhl M; Tessonnier T; Mairani A; Debus J; Herfarth K
    Radiother Oncol; 2024 Sep; 198():110418. PubMed ID: 38944346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
    Iannalfi A; D'Ippolito E; Riva G; Molinelli S; Gandini S; Viselner G; Fiore MR; Vischioni B; Vitolo V; Bonora M; Ronchi S; Petrucci R; Barcellini A; Mirandola A; Russo S; Vai A; Mastella E; Magro G; Maestri D; Ciocca M; Preda L; Valvo F; Orecchia R
    Neuro Oncol; 2020 Sep; 22(9):1348-1358. PubMed ID: 32193546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma.
    Mima M; Demizu Y; Jin D; Hashimoto N; Takagi M; Terashima K; Fujii O; Niwa Y; Akagi T; Daimon T; Hishikawa Y; Abe M; Murakami M; Sasaki R; Fuwa N
    Br J Radiol; 2014 Jan; 87(1033):20130512. PubMed ID: 24288399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors.
    Rotondo RL; Folkert W; Liebsch NJ; Chen YL; Pedlow FX; Schwab JH; Rosenberg AE; Nielsen GP; Szymonifka J; Ferreira AE; Hornicek FJ; DeLaney TF
    J Neurosurg Spine; 2015 Dec; 23(6):788-97. PubMed ID: 26340383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan.
    Demizu Y; Imai R; Kiyohara H; Matsunobu A; Okamoto M; Okimoto T; Tsuji H; Ohno T; Shioyama Y; Nemoto K; Nakano T; Kamada T;
    Radiother Oncol; 2021 Jan; 154():1-5. PubMed ID: 32941958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Oncologic Outcomes and Treatment-Related Toxicity of Carbon Ion Radiotherapy and En Bloc Resection for Sacral Chordoma.
    Yolcu YU; Zreik J; Wahood W; Bhatti AUR; Bydon M; Houdek MT; Rose PS; Mahajan A; Petersen IA; Haddock MG; Ahmed SK; Laack NN; Jethwa K; Jeans EB; Imai R; Yamada S; Foote RL
    JAMA Netw Open; 2022 Jan; 5(1):e2141927. PubMed ID: 34994795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center-a single-center experience.
    Mattke M; Ohlinger M; Bougatf N; Harrabi S; Wolf R; Seidensaal K; Welzel T; Röder F; Gerum S; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Uhl M; Debus J
    Strahlenther Onkol; 2023 Feb; 199(2):160-168. PubMed ID: 36149438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine.
    Guan X; Gao J; Hu J; Hu W; Yang J; Qiu X; Hu C; Kong L; Lu JJ
    Radiat Oncol; 2019 Nov; 14(1):206. PubMed ID: 31752953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases.
    Imai R; Kamada T; Araki N;
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):322-327. PubMed ID: 27084649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.
    Cai X; Du Y; Wang Z; Li P; Yu Z; Zhang Q; Zhang Z
    Radiat Oncol; 2020 Aug; 15(1):209. PubMed ID: 32859234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcome of Sacral Chordoma Patients Treated with Pencil Beam Scanning Proton Therapy.
    Walser M; Bojaxhiu B; Kawashiro S; Tran S; Beer J; Leiser D; Pica A; Bachtiary B; Weber DC
    Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e578-e585. PubMed ID: 34340918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of carbon ion radiotherapy in 152 patients.
    Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Kraft G; Wannenmacher M; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):631-40. PubMed ID: 14751537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon ions therapy as single treatment in chordoma of the sacrum. Histologic and metabolic outcome studies.
    Evangelisti G; Fiore MR; Bandiera S; Barbanti Brodano G; Terzi S; Girolami M; Pipola V; Righi A; Nanni C; Fanti S; Ghermandi R; Molinelli S; Orecchia R; Boriani S; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4002-4009. PubMed ID: 31115029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy.
    Molinelli S; Magro G; Mairani A; Allajbej A; Mirandola A; Chalaszczyk A; Imparato S; Ciocca M; Fiore MR; Orlandi E
    Radiother Oncol; 2021 Oct; 163():209-214. PubMed ID: 34506829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation study.
    Makishima H; Yasuda S; Isozaki Y; Kasuya G; Okada N; Miyazaki M; Mohamad O; Matsufuji N; Yamada S; Tsuji H; Kamada T;
    Cancer Sci; 2019 Jan; 110(1):303-309. PubMed ID: 30417485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.